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Summary
Weight loss programmes appeal mainly to women, prompting calls for gender-specific
programmes. In the United Kingdom, general practitioners (GPs) refer nine times as
many women as men to community weight loss programmes. GPs endorsement and
offering programmes systematically could reduce this imbalance. In this trial, consecu-
tively attending patients in primary care with obesity were invited and 1882 were
enrolled and randomized to one of two opportunistic 30-second interventions to sup-
port weight loss given by GPs in consultations unrelated to weight. In the support arm,
clinicians endorsed and offered referral to a weight loss programme and, in the advice
arm, advised that weight loss would improve health. Generalized linear mixed effects
models examined whether gender moderated the intervention. Men took effective
weight loss action less often in both arms (support: 41.6% vs 60.7%; advice: 12.1% vs
18.3%; odds ratio (OR) = 0.38, 95% confidence interval (CI), 0.27, 0.52, P < .001) but
there was no evidence that the relative effect differed by gender (interaction P = .32).
In the support arm, men accepted referral and attended referral less often, 69.3% vs
82.4%; OR = 0.48, 95% CI, 0.35, 0.66, P < .001 and 30.4% vs 47.6%; OR = 0.48, 95%
CI, 0.36, 0.63, P < .001, respectively. Nevertheless, the gender balance in attending
weight loss programmes closed to 1.6:1. Men and women attended the same number
of sessions (9.7 vs 9.1 sessions, P = .16) and there was no evidence weight loss differed
by gender (6.05 kg men vs 4.37 kg women, P = .39). Clinician-delivered opportunistic
30-second interventions benefits men and women equally and reduce most of the gen-
der imbalance in attending weight loss programmes.
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1 | BACKGROUND
The prevalence of obesity in men and women is similar1 as is the
proportion of men and women with obesity who are trying to lose
weight.2 However, findings from high-income countries indicate that
men are less likely to attend weight loss programmes.3-5 For example,
in an audit of 1.3 m people attending a weight loss programme in the
United Kingdom, only 5% of users were men.3 This matters because
self-directed weight loss attempts are less successful than supported
attempts.6 Men are also less likely to receive treatment for obesity in
routine clinical practice7,8 and are underrepresented in clinical trials of
weight loss interventions.5,9,10
This gender gap has attracted considerable attention. In 2014, a
series of systematic reviews examined the effect of gender on the
clinical effectiveness and cost-effectiveness of interventions to treat
obesity.5 These found that men expressed a preference for fact-based
advice, delivered in social settings and programmes with a greater
emphasis on physical activity. This has led to efforts to develop
programmes with specific appeal to men, notably the Football Fans in
Training (FFIT) scheme. Here a 12-week programme was developed
for men and delivered in football/soccer clubs, which led to a mean
weight loss of 5.6 kg at 1 year compared with 0.6 kg weight loss
among participants in a waiting list control group.11 However, the
reviews also showed that men who attended mixed gender
programmes were successful in losing weight. Indeed, once enrolled,
men were less likely than women to drop out of programmes than
women and lost relatively more weight.5 Surprisingly, there has been
little attention given to attracting more men to existing mixed gender
community weight loss group programmes that are already known to
be effective.12-15 This approach is likely to be less costly and quicker
to implement than developing, evaluating, and scaling up novel
gender-specific schemes since it could use the established population
scale infrastructure for weight management.
In routine clinical practice in the United Kingdom, only 10% of pri-
mary care referrals to community weight loss programmes are for
men.4,16 However, this in itself does not show whether clinicians do
not offer referrals to men or whether men decline it. In the current
pre-planned exploratory study, we examine how men react to an
opportunistic face-to-face brief intervention by a primary care clini-
cian compared with women and whether this closes the gender gap in
engagement in a weight loss programme.
2 | METHODS
2.1 | Study design and participants
The trial was approved by the NHS Research Ethics Service and regis-
tered prospectively ISRCTN: 26563137. The protocol and the primary
outcome have been published previously.17,18 The study was a paral-
lel, two-arm randomized trial of a brief intervention for the treatment
of obesity. Researchers screened consecutively attending patients at
general practices in England. Patients who were identified as having
obesity using ethnic specific cut-offs were invited to participate.19 If
they agreed they were screened for eligibility. People with limited
English, people who were already attending or had attended a struc-
tured weight loss programme in the last 3 months, or women who
were or were intending to become pregnant were excluded.
At the end of the consultation, clinicians randomly delivered one
of two opportunistic brief interventions to all eligible participants. In
the “support” arm, clinicians endorsed, offered, and facilitated a refer-
ral to one of two commercially delivered 12-week weight loss
programmes, which were offered free of charge, as in the English
NHS. The number of people who accepted the referral was recorded
and they were given an appointment before leaving the practice. Both
programmes are well known in the United Kingdom and are adver-
tised in the community, mainly to women who represent 95% of
attendees.3 In the “advice” (control) arm, clinicians advised partici-
pants to lose weight to benefit their health but did not offer referral
to a weight loss programme. Both the support and advice interven-
tions were designed to be delivered in 30 seconds. The trial showed
that when clinicians opportunistically endorse, offer, and facilitate a
referral of unselected patients with obesity to a community weight
loss programme, this was well received and led to greater weight loss
at 1 year than when clinicians advised weight loss alone.17,18
What is already known about this subject?
• Structured community weight loss programmes are more
effective in achieving weight loss than unguided weight
loss attempts.
• Such programmes are used overwhelming by women,
with one in 20 users being men. Even when referred by
GPs, 1 in 10 are men. Community weight loss
programmes present themselves as highly feminized.
• Men express preferences for weight loss support that
runs differently and it is assumed that men's behaviour
and preferences are immutable and that weight loss
programmes tailored to men are required.
What this study adds
• In this trial, GPs opportunistically offered weight loss sup-
port, including referral to community weight loss
programmes to unselected patients with obesity attend-
ing for routine medical care.
• Seven in 10 men accepted a referral and were nearly as
likely as women to do so. Three in 10 men compared with
5 in 10 women attended the programme. This uptake
closed the gender gap in referrals from 9:1 to 1.6:1.
• When GPs endorse and offer referral, this removes most
of the gender gap in uptake of weight management
support.
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At 3 and 12 months we assessed the actions that people had
taken to lose weight. We defined taking “some action” as any self-
directed effort to control diet or increase activity. We defined taking
“effective action” as following a total or partial meal-replacement
weight loss programme, taking or list at, or attending a weight loss
programme at either three or 12 months since there is evidence that
each of these approaches is more effective than self-directed action.6
We assessed the number of attendances using data from Slimming
World, the weight loss programme chosen by 94% of participants
who accepted a referral in the support arm. Weight was measured in
light clothing at baseline and 12 months.
2.2 | Outcomes and statistical analyses
For all analyses, we used generalized linear mixed effects models.
The link function was either a logistic term for binary outcomes or
identity function for continuous outcomes. Participant randomiza-
tion was stratified by general practice, so this was added as a ran-
dom effect for all analyses. Analyses were conducted in SPSS
version 23.
2.2.1 | Did trial enrolment differ by gender?
Of those invited to participate, we examined whether men were more
or less likely to be enrolled. The outcome variable was trial enrolment
and the denominator was all those screened with an eligible body
mass index (BMI) and body fat percentage. We examined whether any
differences between genders could be explained by the prevalence of
exclusion criteria (eg, pregnancy, recently or currently attending a
weight loss programme).
2.2.2 | Did gender moderate the effect of the
intervention on weight loss attempts, use of effective
aids to weight loss, or weight loss?
We examined whether gender moderated the effectiveness of the
intervention in promoting action to lose weight. The model to do so
included baseline weight, trial arm, and the interaction between gen-
der and trial arm. The denominator was all enrolled participants. For
the first analysis, the outcome variable was any reported action to
lose weight (ie, self-directed efforts or effective action). For the sec-
ond analysis, the outcome variable was people specifically reporting
taking effective action to manage their weight.
We also examined whether the effect of trial arm on weight
loss differed by gender; including baseline weight, trial arm, gen-
der, and the interaction between gender and trial arm. The out-
come variable was weight at 12 months. We weighed 1419 (75%)
participants at 12 months. Otherwise, we imputed missing weights
at 12 months using the baseline observation carried forward
(BOCF) approach.
2.2.3 | Did men and women differ in the response
to clinicians' brief interventions?
In the support arm only, we examined whether gender was associated
with accepting the clinician's referral to a weight loss programme (ie,
telling the clinician that they would attend). The denominator was
everybody in the support arm. We also examined whether men dif-
fered from women in the likelihood of attending the programme at
least once, which amounts to acting on the clinician's recommenda-
tion. We assessed attendance among all those randomized to the sup-
port arm and among those who accepted the referral. To examine
whether the programme was acceptable to those who experienced it
at least once, we examined whether mean number of attendances at
the programme differed by gender, with the denominator being all
those who attended at least once.
3 | RESULTS
3.1 | Did trial enrolment differ by gender?
Between 4 June 2013 and 23 December 2014, 2730 people with
obesity were offered enrolment in the trial. Of these, 1637 were
women and 1064 were men. Data for gender was missing for
29 potentially eligible patients and these people were excluded from
further analyses. A greater proportion of men who were potentially
eligible were enrolled compared with women (75.8% vs 65.7%, odds
ratio (OR) = 1.63, 95% confidence interval (CI), 1.36, 1.95, P < .001).
This was because a smaller proportion of men were not eligible to
participate compared with women (3.9% vs 13.3%, OR = 0.35, 95%
CI, 0.26, 0.48, P < .001), primarily because men were less likely to
be currently or recently participating in a weight loss programme,
although pregnancy or intended pregnancy also excluded some
women (Table 1). Clinicians deemed it inappropriate to make an
opportunistic brief intervention to the same proportion of men and
women (4.5%, OR = 1.00, 95% CI, 0.71, 1.39, P = .99). There was
no evidence of gender differences in the proportion of people who
declined to participate (16% vs 17%, OR = 0.93, 95% CI 0.75,
1.15, P = .50).
3.2 | Did gender moderate the effect of the
intervention on weight loss attempts, use of effective
aids to weight loss, or weight loss?
Data on actions to lose weight were available for 1560 participants
(657 men and 903 women) (Table 2). The clinician's offer of support
increased the proportion of people taking action to manage their
weight from 83.0% in the advice arm to 88.9% OR = 1.62, 95% CI,
1.21, 2.16, P = .001 but there was no evidence overall that the pro-
portion of men and women taking action differed (OR = 0.75, 95% CI,
0.47, 1.20, P = .23). There was also no evidence that men and women
differed in their response to the support intervention; 87.7% of men
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and 89.6% of women in the support arm took action compared with
83.0% of men and 83.1% of women in the advice arm (P = .60 for the
interaction).
Altogether, 52.8% of participants in the support arm took effec-
tive action to manage their weight compared with 15.6% in the advice
arm (OR = 6.12, 95% CI, 4.82, 7.78, P < .001). For the main effects of
the model, men were less likely than women to take effective action
in both support and advice arms, with 41.6% of men and 60.7% of
women taking effective action in the support arm and 12.1% of men
and 18.3% of women in the advice arm doing so (OR = 0.38, 95% CI,
0.27, 0.52, P < .001). There was no evidence that the relative effect of
the support arm differed by gender (P = .32 for the interaction).
At 12 months, we collected weight data for 1419 participants
(73% of men and 77% of women) and weight loss was 2.43 kg (6.49)
in the support arm and 1.04 kg (5.50) in the advice arm. In the support
arm, weight loss in men was 2.39 kg (6.71) compared with 2.46 kg
(6.32) in women. In the advice arm, weight loss in men was 0.68 kg
(5.71) compared with 1.32 kg (5.33) in women. There was no evidence
that gender moderated the relationship between intervention group
and weight loss (P = .26 for the interaction).
TABLE 1 Proportion of potentially eligible patients enrolling in the trial by gender
Men n Women n Missing gender n OR (95% CI)a Sig
Eligible BMI/invited 1064 1637 29 – –
Declined participation (%) 167 (15.7) 271 (16.6) 18 0.93 (0.75, 1.15) 0.50
Not eligible for other reasons (%) 41 (3.9) 218 (13.3) 3 0.35 (0.26, 0.48) <0.001
Pregnant 0 (0) 34 (2.1) 0 – –
Participating in weight loss programme 14 (<1) 58 (3.5) 1 – –
Participated in weight loss programme in past 3 mo 13 (1.2) 64 (3.9) 1 – –
Visiting clinician for weight loss 5 (<1) 21 (1.3) 0 – –
Poor English language skills 3 (<1) 5 (<1) 0 – –
Clinician deemed brief intervention participation
inappropriate (%)
48 (4.5) 74 (4.5) 0 1.00 (0.71, 1.39) 0.99
Enrolled (%) 806 (75.8) 1076 (65.7) 0 1.63 (1.36, 1.95) <0.001
Abbreviation: BMI, body mass index.
aMen compared with women (reference).
TABLE 2 Self-reported actions and weight loss for men and women in the advice and support arm
Advice only
men (N = 340)
Advice only
women (N = 460)
Advice
total (N = 800)
Support
men (N = 317)
Support
women (N = 443)
Support
total (N = 760)
Effective action 41 (12.1) 84 (18.3) 125 (15.6) 132 (41.6) 269(60.7) 401 (52.8)
Some action 241 (70.9) 298 (64.8) 539 (67.4) 146 (46.1) 128 (28.9) 274 (36.1)
No action 58 (17.1) 78 (17.0) 136 (17.0) 39 (12.3) 46 (10.4) 85 (11.2%)
12-mo weight loss
(BOCF) (kg)
0.68 (5.71) 1.32 (5.33) 1.04 (5.50) 2.39 (6.71) 2.46 (6.32) 2.43 (6.49)
TABLE 3 Proportion of men and women accepting and attending the referral and weight loss in the support arm
Men Women OR (95% CI) Sig
Total randomized to support arm, n 401 539 – –
Accepted referral, n (%) 278 (69.3) 444 (82.4) 0.48 (0.35, 0.66) <0.001
Attended weight loss programme (overall), n (%) 122 (30.4) 257 (47.6) 0.48 (0.36, 0.63) <0.001
– – – Mean difference (95% CI) –
Number of sessions attended, mean (SD) 9.66 (3.24) 9.08 (3.47) 0.62 (−0.25, 1.48) 0.16
12-mo weight loss BOCF in support arm (N = 940), mean
(SD)
2.39 (6.71) 2.46 (6.32) −0.53 (−1.42, 0.37) 0.25
12-mo weight loss BOCF in participants who attended
weight loss programme (N = 379), mean (SD)
6.05 (8.56) 4.37 (7.57) 0.80 (−1.01, 2.62) 0.39
Abbreviations: BOCF, baseline observation carried forward; CI, confidence interval; OR, odds ratio.
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3.3 | Did men and women differ in the response to
clinicians' brief interventions?
There were 401 men and 539 women assigned to the support arm
and were offered a referral to a weight loss programme. Men were
less likely than women to accept the referral (69.3% vs 82.4%;
OR = 0.48, 95% CI, 0.35, 0.66, P < .001) (Table 3).
Among all those in the support arm, 379 (40.3%) people attended a
weight loss programme, but men were less likely to do so than women
(30.4% vs 47.6%; OR = 0.48, 95% CI, 0.36, 0.63, P < .001). In those
accepting a referral, men were less likely to attend the programme
(43.2% vs 57.9%; OR = 0.58, 95% CI, 0.43, 0.79, P < .001). Of those
who attended the programme at least once, there was no evidence of a
difference by gender in the number of sessions attended (9.7 vs 9.1;
mean difference = 0.62, 95% CI, −0.25, 1.48, P = .16). Among this
group, men lost slightly but not significantly more weight than women
at 12 months; 6.05 kg (8.56) compared with 4.37 kg (7.57), mean
adjusted difference = 0.80, 95% CI, −1.01, 2.62 (P = .39) (Table 3).
4 | DISCUSSION
4.1 | Abstract
More than four in five men and women opportunistically approached
in a primary care clinic volunteered to enrol in a trial of brief interven-
tions for obesity. Randomization to a clinician offering, endorsing, and
facilitating a referral to a weight loss programme increased the pro-
portion of men and women taking action to lose weight. There was no
evidence of a gender difference in the effect of the intervention itself,
but overall, men were less likely to take effective action to manage
their weight than women. This was manifest in a greater proportion of
men declining the clinician's offer of a referral and, among those who
agreed to it, a smaller proportion of men attending the programme
compared with women. However, once enrolled in the programme,
men attended a similar number of sessions as women and there was
no evidence that weight loss at 12 months differed by gender.
4.2 | Strengths and limitations
This is the first analysis of the effect of an intervention that can be
delivered by clinicians in routine practice to increase the engagement
of men to established mixed gender weight loss programmes. It is
based on a randomized controlled trial in which 75% of participants
were weighed, which is higher than the typical follow-up in similar
weight loss trials (63%).20
Whilst we planned these exploratory analyses17 these subgroup
analyses did not inform the sample size calculations. In many cases,
we did not detect differences between men and women, but the trial
was not planned to have sufficient power to detect these subgroup
effects and the precision of the confidence intervals means that we
may have missed modest but important differences in effectiveness
by gender. We cannot therefore conclude that the intervention effect
does not differ by gender, only that there is no evidence that it does
so and that there are no moderate or large differences.
4.3 | Comparison with existing literature
Five percent of paying customers of the commercial weight loss group
programmes are men,3 whilst 10% of people referred by clinicians to
these programmes are men.4,16 Why might men be so underrepre-
sented in such programmes? Previous findings have suggested that
men view community weight loss programmes as feminized
spaces.21,22 The evidence here is that such a perception can be easily
overcome by clinicians endorsing and offering referral. We asked par-
ticipants to rate the acceptability of the referral to a weight loss pro-
gramme immediately after the consultation, and there was no
evidence that scores differed between men and women. Moreover,
men's behaviour in this trial shows clear evidence of the broad accept-
ability of these programmes to most men. Here 39% of participants in
the weight loss programme were men and the gender ratio in atten-
dance was 1:1.6 compared with 1:10 in routine primary care. This is
reinforced by data from two clinical trials where men and women
were offered an equal opportunity to attend a weight loss programme
by receiving an invitation letter to do so.10,13 Around a third of people
enrolled were men, a gender ratio of 1:1.9 in a trial where the gender
mix of the invited population was known. As Figure 1 suggests, most
of the gender imbalance in paying customers appears to be due to
men's reluctance to enrol in such programmes. However, this trial sug-
gests that the gender imbalance in routine primary care is because cli-
nicians offer programmes mainly to women, perhaps because they
perceive such programmes to be gendered. Data from this trial shows,
however, that three quarters of the large gender imbalance is
removed by clinicians spending 30 seconds to endorse and offer such
a programme.
Our findings also indicate that when men attended at least one
session of the programme, they remained as engaged as women
(attending the same number of total sessions) and lost a similar
amount of weight. This is consistent with evidence from a clinical
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similar programmes.3 Once men are enrolled in these programmes,
they find them appropriate and engagement does not differ by
gender.
Many national guidelines recommend that clinicians refer men
and women with obesity to behavioural weight loss programmes.23-25
However, the frequency of brief interventions and attendance at
programmes is much lower than occurred in this trial,26,27 suggesting
that clinicians are not adhering to guidelines. There is evidence that clini-
cians do not offer referrals to weight loss programmes opportunistically
because they are concerned about the best way to initiate conversa-
tions about weight loss.28,29 Where conversations do occur, these are
usually initiated by patients not clinicians.26 Since men are less likely to
problematize their weight than women,22 they may raise the issue with
their clinician less often, reducing the likelihood of being offered sup-
port. These results should reinforce clinicians' sense of capability at hav-
ing these conversations. A relatively brief intervention with a clinician
was able to overcome a preference against apparently feminine weight
loss programmes that many had regarded as immutable.
4.4 | Implications for research and practice
Currently, clinician referrals represent a small proportion of all people
using community weight loss programmes; most users are self-payers,
and nearly all of them are women. Research is needed to understand
how else we can counter the perception that these programmes are
designed for and best suited to women. If a 30-second intervention
by a clinician can remove three quarters of the gender imbalance, this
should encourage efforts to do so for self-payers, because this per-
ception seems easily malleable.
These results have direct application to clinical practice. It appears
that clinicians mainly offer to refer women to weight loss
programmes, perhaps because they share the widespread belief that
these are feminized and unsuitable for men. However, clinicians can
be reassured that their endorsement appears to counter that and
three quarters of the gender imbalance in referrals can be removed by
clinicians endorsing and offering such programmes equally to men and
women. Men and women benefited markedly and equally from these
brief opportunistic interventions.
Currently there is no direct evidence that gender-specific inter-
ventions, for example those delivered in sports clubs or at work, are
more effective or cost-effective for men than existing evidence-based
programmes. The FFIT programme, specifically developed and tested
for men resulted in a mean weight loss of 5.6 kg at 1 year with an
intervention lasting 12 sessions and costing an estimated £680.11 A
trial of a mixed gender community weight loss group for 12 or
52 weeks shows mean weight losses at 1 year of 4.8 and 6.8 kg cost-
ing £60 or £195, respectively.15 Whilst gender-specific programmes
may be useful for men who are unwilling to attend existing services,
such programmes are not yet widely available. Policy might therefore
focus more on implementing brief interventions as a way to reach
men rather than on developing bespoke weight loss programmes
for them.
5 | CONCLUSIONS
Brief opportunistic interventions by clinicians to unselected patients
with obesity to endorse, offer, and facilitate a referral to an effective
weight loss programme slightly increase the proportion of men and
women taking action on their weight and markedly increase the pro-
portion taking effective action. Brief opportunistic interventions work
equally effectively in men and women and remove three quarters of
the gender imbalance in referrals to these programmes seen in routine
care. Once enrolled, men attend and achieve as much weight loss as
women do. Clinicians can use these findings to more frequently offer
referrals to these programmes for men as well as women.
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